Petmed Express Inc  

(Public, NASDAQ:PETS)   Watch this stock  
Find more results for PETS
+0.08 (0.57%)
Sep 18 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 13.96 - 14.11
52 week 12.13 - 16.95
Open 14.05
Vol / Avg. 0.00/120,085.00
Mkt cap 285.19M
P/E 15.54
Div/yield 0.17/4.83
EPS 0.91
Shares 20.27M
Beta 1.32
Inst. own 67%
Oct 20, 2014
Q2 2014 Petmed Express Inc Earnings Release (Estimated) - 8:00AM EDT - Add to calendar
Jul 25, 2014
Petmed Express Inc Annual Shareholders Meeting
Jul 21, 2014
Q1 2014 Petmed Express Inc Earnings Call
Jul 21, 2014
Q1 2014 Petmed Express Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2014
Net profit margin 6.86% 7.70%
Operating margin 10.80% 12.09%
EBITD margin - 12.46%
Return on average assets 24.27% 23.72%
Return on average equity 28.03% 26.78%
Employees 190 -
CDP Score - -


1441 SW 29 AVENUE
United States - Map
+1-954-9794788 (Phone)
+1-800-6008285 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


PetMed Express, Inc. (PetMed Express) and its subsidiaries, doing business as 1-800-PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. The Company markets its products through national television, online, and direct mail/print advertising campaigns. The Company offers a selection of products for dogs and cats. As of March 31, 2013, the Company�s product line contains approximately stock keeping units (SKUS). These products include brands of medication, such as Frontline Plus, K9 Advantix II, Advantage II, Heartgard Plus, Sentinel, Revolution, and Rimadyl. It also offers for sale additional pet supplies on its Website, which are drop shipped to its customers by third parties. These pet supplies include food, beds, crates, stairs, strollers, and other pet supplies.

Officers and directors

Robert C. Schweitzer Independent Chairman of the Board
Age: 68
Bio & Compensation  - Reuters
Menderes Akdag President, Chief Executive Officer, Director
Age: 52
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Bruce S. Rosenbloom Chief Financial Officer, Treasurer
Age: 44
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Frank J. Formica Independent Director
Age: 69
Bio & Compensation  - Reuters
Gian M. Fulgoni Independent Director
Age: 66
Bio & Compensation  - Reuters
Ronald J. Korn Independent Director
Age: 73
Bio & Compensation  - Reuters